Microfluidic Assay Device with Magnetic Particle Transport
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and managing heart failure are complex, expensive, and often require hospital settings, limiting accessibility and efficiency in detection and monitoring.
Innovation Solution
A microfluidic device method that involves introducing a liquid sample, contacting it with reagents and substrates, and detecting characteristics through a series of interfaces to validate or adjust assay results, enabling efficient detection of analytes like NT-proBNP in a portable and reproducible manner.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex diagnostic procedures are used to ensure accurate heart failure diagnosis, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The diagnostic process is segmented into distinct microfluidic zones: sample introduction zone, reagent mixing zone, reaction zone, and detection zone. Each zone performs a specific function, allowing complex diagnostics to be broken down into manageable, integrated steps that maintain precision while reducing operational complexity
Solution Approach 2:
Multiple diagnostic functions (sample preparation, reagent mixing, incubation, and detection) are merged into a single integrated microfluidic device. This consolidation maintains measurement precision through controlled fluid handling while eliminating the need for multiple separate complex procedures
2Reliability
If multiple control measurements are performed to validate assay results, then reliability is improved, but loss of time increases
Solution Approach 1:
Control measurements are prepared in advance within the microfluidic device structure. Control reagents and substrates are pre-positioned in separate channels, allowing simultaneous execution of control and test assays without sequential delays, thus maintaining reliability while minimizing time loss
Solution Approach 2:
The device enables continuous parallel processing of multiple assays including control and test samples. Fluid flow and reactions proceed simultaneously in different channels, maintaining continuous useful action rather than interrupting for sequential control measurements, thereby improving reliability without proportionally increasing total assay time
Data Source
AI summary
An assay method and device can perform at least one (e.g., at least two) assays on a single aliquot of a sample liquid. The device can mix a sample liquid with assay reagents including magnetically susceptible particles. The device is configured to create a sample liquid-air interface with the sample liquid. The magnetically susceptible particles can be located (via an applied magnetic field) at the liquid-air interface when a second liquid contacts the interface to form a liquid-liquid interface. The magnetic particles travel across the liquid:liquid interface to the second liquid. The magnetically susceptible particles are configured to transport an analyte across the interface into the second liquid. An assay for the analyte is performed in the second liquid. An assay for another analyte can also be performed in the sample liquid.